Lindt’s latest results delivered a neat little paradox. The Swiss chocolate-maker missed sales estimates by a whisker, yet still managed to beat on profit, raise its dividend, and talk up the resilience of premium indulgence. In other words, consumers may be getting choosier, but plenty are still willing to pay up for a gold-wrapped truffle when the world feels grim.
Lindt & Sprüngli reported 2025 sales of CHF 5.92 billion (about $7.6 billion), up from CHF 5.47 billion a year earlier, but just below the CHF 5.93 billion analysts had expected. Net income rose to about CHF 727 million from CHF 672 million, while EBIT climbed nearly 10% to CHF 971 million, slightly ahead of forecasts.
The standout detail was how Lindt got there. Organic sales growth came in at 12.4%, driven largely by a hefty 19% increase in prices. Volumes fell 6.6%, but that drop was less severe than expected, suggesting customers grumbled and then kept buying anyway. EBIT margin edged up to 16.4% from 16.2%, showing the company largely protected profitability despite record cocoa costs and a volatile operating backdrop.
Lindt also proposed a higher dividend of CHF 1,800 per registered share, up from CHF 1,500, and unveiled a new CHF 1 billion share buyback program. So while the top line missed consensus by the financial equivalent of a chocolate shaving, management still behaved like a company feeling pretty good about itself.
That said, the outlook was not all sugar rush. Lindt cut its 2026 organic sales growth forecast to 4% to 6%, down from its prior 6% to 8% target. Management blamed geopolitical instability, particularly in the Middle East, saying weaker consumer confidence and softer tourism had already started to weigh on demand. That matters because Lindt sells a lot of chocolate in airports and tourist-heavy cities, where impulse purchases and gifting still do a lot of heavy lifting.
The company also said it expects further price increases in the first half of 2026, including a double-digit hike for Easter, and sees volumes falling in the first half before recovering later in the year.
Then came the curveball. Lindt said users of GLP-1 weight-loss drugs are actually buying more premium chocolate, not less. Citing internal data based on Circana research, the company said premium chocolate sales among U.S. GLP-1 users rose nearly 17% in 2025, versus 6.5% among non-users. CEO Adalbert Lechner’s explanation was simple enough: less mindless snacking, more curated indulgence.
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here.


